NEWSpublisher 2007 :: AngloChinese Investments
SEARCH NEWS
date from:
date to:
company:
search for string:
NEWS SECTIONS
COMPANY GROUPS
TOP NEWS
» 23/07/2009 [Company watch]
China Aoxing Pharmaceutical Corp. Receives Renewal of GMP Certification for Capsule Dosage Form of Pharmaceutical Products
» 15/03/2010 [Industry news]
Recordati S.p.A And Lee Pharmaceutical Announce Partnership For Zanidip(R) In China
» 26/10/2009 [Finance]
China Growth to Remain Fast in Fourth Quarter, Official Says
» 17/08/2009 [Industry news]
Chindex Posts Profit on Product Sales, Health Services
» 07/05/2010 [Industry news]
Hong Kong: Recall of all products manufactured by Quality Pharmaceutical Lab Ltd
COMPANY NEWS back to previous page show list
»02/09/2009 [Company watch]
Sinopharm Signs Up 9 Cornerstone Investors In $1 Billion IPO Source

China National Pharmaceutical Group Corp. has signed up nine cornerstone investors that will subscribe to a combined US$195 million worth of shares in the company\'s US$1 billion Hong Kong initial public offering, a person familiar with the deal said Tuesday.

 
China National Pharmaceutical Group Corp. has signed up nine cornerstone investors that will subscribe to a combined US$195 million worth of shares in the company\'s US$1 billion Hong Kong initial public offering, a person familiar with the deal said Tuesday. According to the person, the strategic investors are China Life Insurance Co. (LFC), Bank of China Ltd. (3988.HK), China Construction Bank Corp. (0939.HK), the Government of Singapore Investment Corp., Och-Ziff Capital Management LLC ( OZM), Value Partners Group Ltd. (0806.HK), Martin Currie Investment Management Ltd., Bank of East Asia Ltd. (BKEAY), and China Chengtong Development Group Ltd. (0217.HK). The Chinese company, also known as Sinopharm Group, is the country\'s largest pharmaceutical company by sales revenue and is planning to list in Hong Kong next month, according to a term sheet seen by Dow Jones Newswires on Monday.It plans to sell 545.7 million shares, with an option to sell an additional 81.9 million depending on demand, the document said. The state-owned company plans to use the proceeds to expand its distribution coverage and retail network, acquire pharmaceutical products, and upgrade its logistics and information technology systems, according to the term sheet. Morgan Stanley (MS), China International Capital Corp., and UBS AG (UBS) are the bookrunners of the IPO.

AngloChinese Investments ltd.
Home | Company news | TOP 50 | Events | About us
C&F Bright Solutions ltd.